Notably, kallistatin levels decrease in animal models and humans with inflammatory disorders, suggesting its role in metabolic disorders under excess oxidative stress and inflammation, highlighting its potential as a biomarker for PCOS. The gene discussed is SERPINA4; the disease is polycystic ovary syndrome.